Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Updates from ASCO 2024 in gastrointestinal tumours

Share :

Best of ASCO® 2024 Miami Symposium

12 - 13 Jul 2024
Published: 12 Jul 2024
Views: 32
Rating:
Save
Dr Samuel Kareff - University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, USA

Dr Samuel Kareff, speaks to ecancer at the Best of ASCO®️ 2024 Miami Symposium about the updates from ASCO 2024 discussed in a panel for gastrointestinal tumours.

He first highlights the ESOPEC trial which showed that perioperative FLOT was superior in overall and progression free survival to neoadjuvant chemoradiation for oesophageal adenocarcinoma.

Dr Kareff then discusses the next steps for gastrointestinal tumours touching on an over reliance on ctDNA guidance of adjuvant therapy for locally advanced colorectal tumours and hoping for more progress in other tumour types.

Related Videos

Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)...
Biomarkers, predictive and prognostic factors of resistance to immunotherapy ( Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain )
12 Jul 2024
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA
Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )
12 Jul 2024
Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2...
Dr Giovanni Randon - The National Cancer Institute of Milan, Milano, Italy
Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer ( Dr Giovanni Randon - The National Cancer Institute of Milan, Milano, Italy )
9 Jul 2024
EAU 2024: Bladder cancer latest
Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea...
EAU 2024: Bladder cancer latest ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio )
9 Apr 2024
Relapsed Refractory Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Hodgkin’s and non-Hodgkin’s lymphomas (NHL)
Dr Jose Sandoval Sus - Memorial Healthcare System, Florida, USA
Hodgkin’s and non-Hodgkin’s lymphomas (NHL) ( Dr Jose Sandoval Sus - Memorial Healthcare System, Florida, USA )
8 Jul 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation